140
frequency in European populations but comparable frequency in East Asian populations, suggesting the advantage 141 of this study in discovering these novel variants. Three novel signals were in linkage disequilibrium (r 2 > 0.6) with 142 missense variants which are monomorphic in European populations (1000 Genomes Project) including rs11235604 143 (p.R220W of ATG16L2, a autophagy-related gene) associated with coronary artery disease. We further 144 investigated enrichment of heritability within 2,868 annotations of genome-wide transcription factor occupancy, and 145 identified 378 significant enrichments across nine diseases (FDR < 0.05) (e.g. NF-κB for immune-related diseases).
146
This large-scale GWAS in a Japanese population provides insights into the etiology of common complex diseases 147 and highlights the importance of performing GWAS in non-European populations. 
150
We conducted a genome-wide association study (GWAS) of 42 diseases in a Japanese population, comprising 151 179,660 patients who participated in the BioBank Japan Project (BBJ) 4,5 and 32,793 population-based controls 152 (Supplementary Table 1 ). The 42 diseases encompassed a wide-range of disease categories; 13 neoplastic 153 diseases, five cardiovascular diseases, four allergic diseases, three infectious diseases, two autoimmune diseases, 154 one metabolic disease, and 14 uncategorized diseases. By including patients with unrelated diagnoses into control 155 samples, we maximized the power of our GWAS ( Supplementary Table 1 and Supplementary Figure 1) . We 156 employed a generalized linear mixed model in our association analysis using SAIGE 6 . Following imputation with 157 1000 Genomes Project Phase 3 reference data (1KG Phase3) 7 , we tested 8,712,794 autosomal variants and 158 207,198 X chromosome variants for association with 42 diseases. We estimated their heritability using linkage 159 disequilibrium score regression (LDSC) analysis 8 ( Supplementary Table 2 ). Consistent with a recent finding in the 160 European population 9 , incorporating the baselineLD model 10 into the LDSC analysis improved heritability estimation 161 in our GWAS (Methods; Supplementary Figure 2 and Supplementary Table 2 ). Although we observed high genomic 162 inflation factors (λGC) for some diseases (e.g. λGC = 1.3 for type 2 diabetes (T2D); Supplementary Table 2 ), LDSC 163 analysis indicated that the majority of the inflated chi-squared statistics originated from polygenic effects rather than 164 confounding biases (e.g. intercept = 1.01 for T2D; Supplementary Table 2 ). Overall, we detected significant 165 associations for 30 diseases at 309 autosomal loci (outside of the HLA region) and nine loci on the X chromosome 166 (P < 5 x 10 -8 ) ( Supplementary Table 3 and 4). Associations at the HLA region have been investigated in detail in a 167 separate article 11 .
7
We further performed conditional analyses in these 318 loci to explore disease-associated variants 169 independent of the lead variants. We detected 52 additional independent signals for 11 diseases (P < 5 x 10 -8 )
170
( Supplementary Table 5 ). The largest number of independent signals in a single locus was seven, found in the 171 FAM84B/POU5F1B locus associated with prostate cancer and in the KCNQ1 locus associated with T2D.
172
For 35 diseases for which we have both male and female patients, we conducted male-and female-173 specific GWAS. We detected 13 additional loci for 10 diseases which were not identified in a sex-combined 174 analysis (P < 5 x 10 -8 ) ( Supplementary Table 6 ). We tested heterogeneity between effect size estimates for males 175 and females using Cochran's Q test. This analysis found seven loci showing significant differences in effect size 176 estimates between sexes (P values of heterogeneity (Phet) < 0.05/13); two asthma loci, a cataract locus, a cerebral 177 aneurysm locus, and a lung cancer locus were specifically associated with females; and a coronary artery disease 178 (CAD) locus and a T2D locus were specifically associated with males.
179
In total, we detected 383 independent signals in 331 loci outside of the HLA region for 30 diseases, of 180 which 45 loci were novel ( Figure 1a , Table 1, Supplementary Table 3 , 4, and 6). Five novel disease-associated 181 variants were rare variants (MAF < 0.01), and four of them had large effect sizes (odds ratio > 2, Figure 1b ). To 182 understand the characteristics of novel and known disease-associated variants, we examined their allele 183 frequencies in East Asian and European populations of 1KG Phase3. Allele frequencies of novel and known 184 variants were of comparable level in East Asian populations (P = 0.35, Figure 1c ). However, novel variants have 185 lower allele frequencies than known variants in European populations (P = 0.0030, Figure 1d ). Although both of 186 novel and known variants have lower allele frequencies in European populations than in East Asian populations, 8 novel variants have larger inter-population differences than known variants (P = 0.0047, Supplementary Figure 3 ).
188
To estimate population specificity in our GWAS results, we compared our results with those reported in previous 189 European GWAS. We utilized publicly available GWAS summary statistics of European populations for 10 diseases
190
(Methods), and tested for consistency in direction of effect between populations at 11 novel and 146 known 
199
We next investigated the potential impact of the disease-associated variants on protein functions
200
( Supplementary Table 7 ). Nine novel variants were in linkage disequilibrium (LD) with missense variants (r 2 > 0.6 in 201 the 1KG Phase3 East Asian populations) ( Table 2 ). Among them, three missense variants are monomorphic in 202 European populations (1KG Phase3); p.R220W of ATG16L2 associated with CAD; p.V326A of POT1 associated 203 with lung cancer; and p.E62G of PHLDA3 associated with keloid ( Figure 2 and Supplementary Figure 5 ). First,
204
ATG16L2 is an autophagy-related gene. Although p.R220W of ATG16L2 is not the lead variant at this locus, 205 conditioning on this variant cancelled the signal of the lead variant (Figure 2a ). Previous GWAS for CAD in 9 European populations did not detect significant associations at this locus 12 (Figure 2a ). These findings suggested 207 that p.R220W of ATG16L2 which is absent in Europeans may be the causal variant. p.R220W of ATG16L2 is also 208 associated with Crohn's disease in a Chinese population 13 , and ATG16L2 is highly expressed in immune cells.
209
Therefore, dysregulated autophagy in immune cells might have an important role in CAD. Second, POT1 is a 210 member of the telombin family and this protein binds to telomeres, regulating telomere length. Missense variants of 211 POT1 have been described to be responsible for several familial cancers [14] [15] [16] . Together with a known association at 212 the TERT locus ( Supplementary Table 3 ), we provide additional evidence that telomere dysregulation is pathogenic 213 for lung cancer. Intriguingly, this association was discovered in the female-specific GWAS, and a significant 214 heterogeneity in effect sizes between males and females was observed (Phet = 7.7x10 -4 ) (Figure 2b ; Supplementary 215 Table 6 ). This finding might help to understand the inter-sex differences in the etiology of lung cancer. Third, 216 p.E62G of PHLDA3 is predicted to have a deleterious effect to its protein function (SIFT score 17 =0; CADD 217 score 18 =33), and we detected a large effect size for keloid (odds ratio = 9.56; 95% CI 5.91-15.45). PHLDA3 is 218 known to be a suppressor of AKT 19 , and upregulated AKT signaling pathway is related to increased collagen 219 production from dermal fibroblasts 20 . Therefore, damaged PHLDA3 may activate the AKT pathway, promoting the 220 development of keloid. Together, our study successfully identified novel potential causal genes which would be 221 hard to be discovered by GWAS in European populations due to restrictive European allele frequencies.
222
We also investigated the potential impacts of the disease-associated variants on the mRNA levels using 10 > 0.6), regulating the expression of 17 genes in total ( Supplementary Table 8 ); P2RY13, SIAH2, and SIAH2-AS1 for 226 breast cancer; ATP2B1, BET1L, POC1B, and ZNF767 for cerebral aneurysm; CCAT1 and CD40 for Graves's 227 disease; GABPB2 for osteoporosis; MOV10 and WNT2B for pancreatic cancer; CYP2A6 and CYP2B7P1 for 228 peripheral artery disease; ZMIZ1-AS1 for prostate cancer; and STIM1 and TRIM21 for urolithiasis. Intriguingly, the 229 eQTL signals for ATP2B1 which are in LD with a novel variant of cerebral aneurysm (rs11105352) is highly specific 230 to arterial tissues ( Figure 3 ). Since the loss of ATP2B1 in vascular smooth muscle cells induced blood pressure 231 elevation in mice 23 , decreased expression of ATP2B1 in arteries might induce hypertension, which leads to 232 increased risk of cerebral aneurysm.
233
To understand differences in the genetic risks between males and females, we assessed genetic 234 correlations using LDSC 24 between the results of sex-specific GWAS for the 20 diseases (see Methods for 235 selection of diseases). Although most correlations are close to one, correlation of asthma was significantly smaller 236 than one (P = 2.2 x 10 -3 < 0.05/20; Supplementary Figure 6 ). This finding suggested that genetic risks of asthma is 237 slightly different between males and females. To explore the biological mechanism underlying this finding, we 238 estimated the enrichment of the heritability of male or female asthma in the 220 cell-type specific regulatory regions 239 using stratified LD-score regression (S-LDSC) 25 . We found significant enrichments for either of male or female 240 asthma in three annotations; Th0, Th1, and colonic mucosa (P < 0.05/220; Supplementary Figure 6 ). Among them, 241 the colonic mucosa annotation showed significant heterogeneity in the enrichment of heritability (Phet = 0.006 < 242 0.05/3). Recent studies suggested that host-microbiome interactions at intestinal mucosa (gut-lung axis) have important roles in the development of asthma 26, 27 , and our study suggested that the importance of the gut-lung axis 244 in asthma might be different between males and females.
245
To acquire more insights to disease biology, we estimated the heritability enrichments in the binding sites 246 of a variety of transcription factors (TFs) using S-LDSC. We included TF binding sites defined by 2,868 publicly 247 available chromatin immunoprecipitation sequencing (ChIP-seq) datasets for 410 unique TFs (Supplementary 248 Table 9 ). To make mutually comparable data, we began our analysis from the raw sequencing data, and defined TF (Figure 4c ). This analysis also suggested that NKX3-1, a prostate-specific homeobox gene, has an important 260 role in the biology of prostate cancer (Figure 4c ). In addition to this polygenic analysis, the importance of NKX3-1 261 was also suggested by the regional analysis integrating eQTL databases; the risk allele of prostate cancer at 12 NKX3-1 locus (rs4872174-C) was suggested to decrease the expression of NKX3-1 ( Supplementary Table 8 ).
263
Consistently, loss of NKX3.1 expression in human prostate cancers was reported to be correlated with tumor 264 progression 36 . Together, our results confirmed and expanded our current understanding of complex traits in the 265 context of TF activity.
266
In summary, we conducted a large-scale GWAS of 42 diseases in a non-European population and 267 provided rich public resources for genetic studies. Our study provided multiple insights into the etiology of complex 268 traits by integrating annotations of missense variants, eQTL variants, and transcription factor binding site tracks. 
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European populations). The difference in MAF was tested by Mann-Whitney U test, and its P value was provided.
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389
We performed stepwise conditional analysis within ± 1 Mb from the lead variant; we repeated the 390 association test by additionally incorporated the dosages of the identified variants as covariates in SAIGE step 1 391 until we do not detect any significant associations.
392
We also conducted male-specific and female-specific GWAS using the same pipeline as described above,
393
and estimated heterogeneity in the effect size estimates using Cochran's Q test.
394
We set a genome-wide significance threshold at P = 5.0 × 10 -8 . For each disease, we defined a 395 significantly associated locus as a genomic region within ± 1 Mb from the lead variant. When a locus did not include 396 any variants which were previously reported to be significantly associated with the same disease (P < 5.0 × 10 -8 ),
397
we defined it as a novel locus.
399
Estimation of heritability
400
We estimated heritability and confounding bias in our GWAS results with LDSC (v1.0.0) 8 using the baselineLD 401 model (v2.1) 10 which include 86 annotations, including 10 MAF-and 6 LD-related annotations that correct for bias in 402 heritability estimates 9 , and were calculated using 481 East Asian samples in 1KG Phase3. For the analysis using 403 LDSC, we excluded variants in the HLA region (chr6:26 Mb-34 Mb). We also calculated heritability Z-score to 404 assess the reliability of heritability estimation.
405
Absolute quantification of heritability estimation using GWAS results using GLMM can be biased because 406 effective sample size could be different from the true sample size (relative quantification is not biased, and hence
407
GWAS results using GLMM can be applied for genetic correlation analysis and S-LDSC safely). Therefore, to 408 confirm the robustness of heritability estimation in our analysis, we also performed GWAS using generalized linear 409 regression model (GLM). As simple GLM does not account for the bias caused by genetic relationships, we further excluded related samples (Pi-hat by > 0.187), and we analyzed genotype data with PLINK (v1.90) 44 using the same 411 covariates as described above. Heritability estimates based on GWAS using two different methods (SAIGE vs 412 PLINK) were comparable level ( Supplementary Table 2 ).
414

Comparison of GWAS results between populations
415
To compare the GWAS results of our study with those conducted in European populations, we prepared publicly 
423
Pleiotropy
424
We utilized the following variants detected in GWAS for each disease; (i) lead variants in the significantly 425 associated loci, (ii) independent signals detected by conditional analysis, and (iii) lead variants detected in sex-426 specific GWAS. We defined pleiotropic association when these variants were in LD (r 2 > 0.6). We calculated r 2 427 using East Asian samples in the 1KG Phase3 7 by PLINK (v1.90) 44 .
429
Functional annotation of associated variants
430
We utilized the same disease-associated variants as used in the previous section for this analysis. We calculated r 2 431 using East Asian samples (r 2 EAS) and European samples (r 2 EUR) in the 1KG Phase3 7 by PLINK (v1.90) 44 . We 432 annotated disease-associated variants with eQTLs detected in the Japanese population 21 in the following 433 conditions; (i) the lead variants in eQTL study is in LD (r 2 EAS > 0.6) with GWAS variants and (ii) Q value of the lead 434 variants in eQTL study is less than 0.05. We annotated GWAS variants with eQTL detected in the European 435 population (release v7 of GTEx project) 39 in the following conditions; (i) the lead variants of eQTL study is in LD
436
(r 2 EAS > 0.6 and r 2 EUR > 0.6) with GWAS variants and (ii) Q value of the lead variants in eQTL study is less than 437 0.05.
438
For the annotation of exonic nonsynonymous variants, we used ANNOVAR 45 . We annotated GWAS 439 variants with nonsynonymous variants when they are in LD (r 2 EAS > 0.6). GRCh37 coordinates were used in this 440 study.
442
Genetic correlations between sex-specific GWAS
443
We estimated genetic correlations between our GWAS results by LDSC (v1.0.0) 8 using East Asian LD scores which 444 we presented in our previous study 29 . We excluded variants in the HLA region (chr6:26 Mb-34 Mb). We analyzed 445 20 diseases based on two criteria; (i) heritability was reliably estimated (heritability Z-score > 2; Supplementary
446
Table 2); and (ii) both of male and female patients were included.
